Adar Poonawalla Buys 50% of Karan Johar’s Dharma Productions
In a surprising move, Adar Poonawalla, CEO of Serum Institute of India, has purchased a 50% stake in Dharma Productions, Karan Johar’s renowned Bollywood studio. Valued at ₹1,000 crore, this deal signals a new era for the iconic company. Social media users reacted quickly, humorously linking the COVID-19 vaccine maker’s investment to Bollywood’s future projects.
The acquisition sparked a meme fest, with users joking about future films funded by “Covishield profits.” Comedian Uddhav Parab humorously suggested that they might make Student of the Year 3 using vaccine money.
Poonawalla’s Bollywood Boost
Poonawalla’s wife, Natasha, is a close friend of Karan Johar and a prominent Bollywood socialite. She likely influenced this partnership. This strategic collaboration combines Poonawalla’s business insight with Dharma’s creative power. Together, they aim to enhance content production and distribution by utilizing advanced technologies.
Karan Johar Retains Creative Control
Karan Johar, who has led Dharma Productions since the early 2000s, will keep his role as Executive Chairman while holding the remaining 50% stake. Apoorva Mehta will remain the company’s CEO. This partnership opens new doors for Dharma as it adapts to the evolving digital landscape and the global demand for high-quality Indian content.
New Horizons for Bollywood
Many view this merger as a major boost for Bollywood, which has struggled in recent years due to fierce competition from OTT platforms. By combining Dharma’s storytelling expertise with Poonawalla’s resources, this partnership could revitalize the industry. It may also lead to the creation of globally relevant content. The industry watches closely as this new chapter unfolds.
Stay Updated with The News Buzz!
For more Bollywood-Business inspired stories and all the latest news across various topics, follow us at The News Buzz. Don’t miss out on what’s trending!
